Relationship between fasting insulin and cardiovascular risk factors is already present in young men: The Verona Young Men Atherosclerosis Risk Factors Study

European Journal of Clinical Investigation

Volumn 27, Issue 3, 1997, Pages 248-254

  Bonora, E ^a,b   Targher, G ^a   Zenere, M B ^a   Saggiani, F ^a   Cacciatori, V ^a   Tosi, F ^a   Travia, D ^a   Zenti, M G ^a   Branzi, P ^a   Santi, L ^a   Muggeo, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

cardiovascular risk factor; insulin; lifestyle; regional fat distribution; total body fat; young age

Indexed keywords

INSULIN;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BODY FAT; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 8244252289     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1060658.x     Document Type: Article

References (49)

1. Orchad TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 1983;118:326-37.
2. Modan M, Halkin H, Almong S et al. Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985;75:809-17.
3. Zavaroni I, Dall' Aglio E, Bonora E, Alpi O, Passeri M, Reaven GM. Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med 1987; 83:609-12.
4. Bonora E, Zavaroni I, Alpi O et al. Relationships between blood pressure and plasma insulin in nonobese and obese non-diabetic subjects. Diabetologia 1987;30:719-23.
5. Ferrannini E, Buzzigoli G, Bonadonna R et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
6. Zavaroni I, Bonora E, Pagliara M et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinaemia and normal glucose tolerance. N Engl J Med 1989;320:702-6.
7. Facchini F, Chen YDI, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uricacid clearance, and plasma uric acid concentration. JAMA 1991: 266:3008-11.
8. Zavaroni I, Mazza S, Fantuzzi M et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. J Intern Med 1993;234:25-30.
9. Yamada N, Yoshinaga H, Sakurai N et al. Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinaemia or glucose intolerance. Diabetes Care 1994;17:107-14.
10. Cigolini M, Seidell JC, Targher G et al. Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: the European Fat Distribution Study. Metabolism 1995;44:35-40.
11. Reaven GM. Banting lecture: Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
12. De Fronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
13. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22.
14. De Fronzo RA. Glucose intolerance and aging. Diabetes Care 1981:4:493-501.
15. Zavaroni I, Dall'Aglio E, Bruschi F, Bonora E, Alpi O, Pezzarossa A, Butturini U. Effect of age and environmental factors on glucose tolerance and insulin secretion in a worker population. J Am Geriatr Soc 1986;34:271-5.
16. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freedman DS, Berenson GS. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism 1986;35:441-6.
17. Manolio TA, Savage PJ, Burke GL et al. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA Study. Arteriosclerosis 1990;10:430-6.
18. Rönnemaa T, Knip M, Lautala P et al. Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 1991;23:67-72.
19. Bonora E, Zenere M, Branzi P et al. Influence of body fat and its regional localization on risk factors for atherosclerosis in young men. Am J Epidemiol 1992;135:1271-8.
20. Siedel J, Hagele EO, Ziegenhorn J, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
21. Wahlefeld AW. Triglycerides: determination after enzymatic hydrolysis. In: Bergmeyer HU, ed. Methods of enzymatic analysis. New York: Academic Press, 1974:1831-6.
22. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedures for quantification of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
23. Kageyama N. A direct calorimetric determination of uric acid in serum and urine with uricase-catalase system. Clin Chem Acta 1971;31:421-6.
24. Hales CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J 1963;88:137-44.
25. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
26. Bonora E, Targher G, Branzi P et al. Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution. Int J Obes 1996;20:28-36.
27. Bonora E, Zavaroni I, Bruschi F et al. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism? J Clin Endocrinol Metab 1984;59:1121-7.
28. Bonora E, Coscelli C, Butturini U. Relationship between insulin resistance, insulin secretion and insulin metabolism in simple obesity. Int J Obes 1985;9:307-12.
29. Bonora E, Del Prato, S, Bonadonna R et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992;41:1151-9.
30. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761-811.
31. Avogaro A, Tiengo A. Alcohol, glucose metabolism and diabetes. Diabetes Metab Rev 1993;9:129-46.
32. Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994;17:115-19.
33. Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 1983;32:408-11.
34. Janzon L, Berntorp K, Hanson M, Lindell SE, Trell E. Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance test in middle-aged men. Diabetologia 1983;25:86-8.
35. Facchini F, Hollenbeck CB, Jeppesen J, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-30.
36. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, Cruz A. Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men. The European Fat Distribution Study. Atherosclerosis 1991;86:251-60.
37. Folsom AR, Burke GL, Ballew C et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin. Am J Epidemiol 1989;130:911-24.
38. Wattigney WA, Harsha DW, Srinivasan SR, Webber LS, Berenson GS. Increasing impact of obesity on serum lipids and lipoproteins in young adults. The Bogalusa Heart Study. Arch Int Med 1991; 151:2017-22.
39. Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol 1987; 125:364-72.
40. Van Horn LV, Ballew C, Liu K et al. Diet, body size, and plasma lipids-lipoproteins in young adults: differences by race and sex. The CARDIA Study. Am J Epidemiol 1991;133:9-23.
41. Raitakari OT, Porkka KVK, Räsänen L, Viikar JSA. Relations of life-style with lipids, blood pressure and insulin in adolescents and young adults. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 1994;111:237-46.
42. Raitakari OT, Porkka KVK, Taimela S, Telama R, Räsänen L, Viikari JSA. Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol 1994;140:195-205.
43. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989;298:784-8.
44. Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: The Bogalusa Heart Study. Arch Intern Med 1995;155:190-6.
45. Raitakari OT, Porkka KVK, Rönnemaa T, Knip M, Uhari M, Åkerblom HK, Viikari J. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia 1995; 38:1042-50.
46. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales P, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
47. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 1996;93:54-9.
48. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med 1994;154:1842-7.
49. Liu K, Ruth KJ, Flack JM, Jones-Webb R, Burke G, Savage PJ, Hulley SB. Blood pressure in young blacks and whites: Relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Circulation 1996;93:60-6.